A £1m brain-imaging study has just been launched at the University of Cambridge to investigate why people with Down's syndrome (DS) are at such high risk of Alzheimer's disease.
A collaboration between virologists and neuroscientists at Cambridge University has demonstrated how viruses that cross the blood/brain barrier could be exploited to slow down, or even halt, the progress of Parkinson's and other neurodegenerative diseases.
Launch of first ever rapid, objectively-scored GP assessment to differentiate between patients with memory loss due to the earliest signs of Alzheimer's disease and normal memory loss caused by ageing.
There are over 15 million people suffering from Alzheimer's disease globally and the current cost to the economy represents at least one per cent of gross national product.
The details entered on this page will not be used to send unsolicited email and will not be passed on to any 3rd party for any reason. Privacy policy